Herline-Killian, K., Pauers, M. M., Lipponen, J. E., Zrzavy, M. A., Gouveia Roque, C., McCurdy, E. P., Chung, K. M., & Hengst, U. (2025). Modulation of CREB3L2-ATF4 heterodimerization via proteasome inhibition and HRI activation in Alzheimer’s disease pathology. Cell Death & Disease, 16(1). https://doi.org/10.1038/s41419-025-07586-0

Echeverry‐Quiceno, L. M., Llambrich, S., Heredia‐Lidón, Á., Giménez, S., Rozalem‐Aranha, M., Inampudi, P., Heuzé, Y., Sevillano, X., Fortea, J., & Martínez‐Abadías, N. (2025). Potential of facial biomarkers for Alzheimer’s disease and obstructive sleep apnea in Down syndrome and general population. The FASEB Journal, 39(6). Portico. https://doi.org/10.1096/fj.202403009r

Leuzy, A., Bollack, A., Pellegrino, D., Teunissen, C. E., La Joie, R., Rabinovici, G. D., Franzmeier, N., Johnson, K., Barkhof, F., Shaw, L. M., Arkhipenko, A., Schindler, S. E., Honig, L. S., Moscoso Rial, A., Schöll, M., Zetterberg, H., Blennow, K., Hansson, O., & Farrar, G. (2025). Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer’s disease. Alzheimer’s & Dementia, 21(3). Portico. https://doi.org/10.1002/alz.14528

Mielke, M. M., Evans, J. K., Neiberg, R. H., Molina-Henry, D. P., Marcovina, S. M., Johnson, K. C., Carmichael, O. T., Rapp, S. R., Sachs, B. C., Ding, J., Shappell, H. M., Luchsinger, J. A., Espeland, M. A., & Hayden, K. M. (2025). Alzheimer Disease Blood Biomarkers and Cognition Among Individuals With Diabetes and Overweight or Obesity. JAMA Network Open, 8(2), e2458149. https://doi.org/10.1001/jamanetworkopen.2024.58149

Wu, Y., Libby, J. B., Dumitrescu, L., De Jager, P. L., Menon, V., Schneider, J. A., Bennett, D. A., & Hohman, T. J. (2024). Association of ten VEGF family genes with Alzheimer’s disease endophenotypes at single cell resolution. Alzheimer’s & Dementia. Portico. https://doi.org/10.1002/alz.14419

Aivalioti, E., Georgiopoulos, G., Tual-Chalot, S., Bampatsias, D., Delialis, D., Sopova, K., Drakos, S. G., Stellos, K., & Stamatelopoulos, K. (2024). Amyloid-beta metabolism in age-related neurocardiovascular diseases. European Heart Journal. https://doi.org/10.1093/eurheartj/ehae655

Jin, M., & Noble, J. M. (2024). What’s in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer’s Disease. Eneuro, 11(9), ENEURO.0088-24.2024. https://doi.org/10.1523/eneuro.0088-24.2024

Sewell, K. R., Doecke, J. D., Xiong, C., Benzinger, T., Masters, C. L., Laske, C., Jucker, M., Lopera, F., Gordon, B. A., Llibre‐Guerra, J., Levin, J., Huey, E. D., Hassenstab, J., Schofield, P. R., Day, G. S., Fox, N. C., Chhatwal, J., Ibanez, L., … Roh, J. H. (2024). Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer’s disease. Alzheimer’s & Dementia, 20(11), 7923–7939. Portico. https://doi.org/10.1002/alz.14270

Oveisgharan, S., Yu, L., de Paiva Lopes, K., Petyuk, V. A., Tasaki, S., Vialle, R., Menon, V., Wang, Y., De Jager, P. L., Schneider, J. A., & Bennett, D. A. (2024). G-protein coupled estrogen receptor 1, amyloid-β, and tau tangles in older adults. Communications Biology, 7(1). https://doi.org/10.1038/s42003-024-06272-9

Honig, L. S., Kang, M. S., Lee, A. J., Reyes-Dumeyer, D., Piriz, A., Soriano, B., Franco, Y., Coronado, Z. D., Recio, P., Mejía, D. R., Medrano, M., Lantigua, R. A., Teich, A. F., Dage, J. L., & Mayeux, R. (2023). Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity. JAMA Network Open, 6(4), e238214. https://doi.org/10.1001/jamanetworkopen.2023.8214

Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., O’Bryant, S., Lai, F., Rosas, H. D., Lee, J. H., … Xu, X. (2023). Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer’s disease: a cross-sectional study. The Lancet Neurology, 22(1), 55–65. https://doi.org/10.1016/s1474-4422(22)00408-2

Miller, M. L., Griepp, D. W., Sun, Y., Tamir, S., Farber, R. S., Otten, M. L., & Al‐Dalahmah, O. (2022). A 53‐year‐old woman with a rapidly progressive, non‐enhancing left frontotemporal lesion. Brain Pathology, 33(2). Portico. https://doi.org/10.1111/bpa.13125

Hewitt, V. L., Miller-Fleming, L., Twyning, M. J., Andreazza, S., Mattedi, F., Prudent, J., Polleux, F., Vagnoni, A., & Whitworth, A. J. (2022). Decreasing pdzd8-mediated mito–ER contacts improves organismal fitness and mitigates Aβ42toxicity. Life Science Alliance, 5(11), e202201531. https://doi.org/10.26508/lsa.202201531

Rippon, B., Palta, P., Tahmi, M., Sherwood, G., Soto, L., Cespedes, S., Mesen, Y., He, H., Laing, K., Moreno, H., Teresi, J., Razlighi, Q., Brickman, A. M., Zetterberg, H., & Luchsinger, J. A. (2022). Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics. Journal of Alzheimer’s Disease, 87(3), 1229–1238. https://doi.org/10.3233/jad-210391

Irace, A. L., Rippon, B. Q., Brickman, A. M., Luchsinger, J. A., & Golub, J. S. (2022). The Laterality of Early Age-Related Hearing Loss and Brain β-Amyloid. Otology & Neurotology, 43(3), e382–e390. https://doi.org/10.1097/mao.0000000000003454

Chhatwal, J. P., Schultz, S. A., McDade, E., Schultz, A. P., Liu, L., Hanseeuw, B. J., Joseph-Mathurin, N., Feldman, R., Fitzpatrick, C. D., Sparks, K. P., Levin, J., Berman, S. B., Renton, A. E., Esposito, B. T., Fernandez, M. V., Sung, Y. J., Lee, J. H., Klunk, W. E., Hofmann, A., … Sperling, R. A. (2022). Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer’s disease: cross-sectional and longitudinal analyses of an observational study. The Lancet Neurology, 21(2), 140–152. https://doi.org/10.1016/s1474-4422(21)00375-6